NASDAQ
Brainstorm Cell Therapeutics Inc. (BCLI) has a fcf yield of -136.82% as of Friday, May 29, 2026. This represents a 113.80% decrease compared to its 12-month average of -63.99%. Free cash flow yield measures free cash flow per share as a percentage of the stock price, indicating cash return potential.
No price data available for this timeframe.